TWI371278B - Storage stable perfusion solution for dihydropteridinones - Google Patents

Storage stable perfusion solution for dihydropteridinones

Info

Publication number: TWI371278B
Authority: TW; Taiwan
Prior art keywords: dihydropteridinones; storage stable; perfusion solution; stable perfusion; solution
Prior art date: 2004-08-14

Application number

TW094127587A

Other languages

English (en)

Other versions

TW200628157A (en

Inventor

Detlef Mohr

Claus Veit

Fridtjof Traulsen

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-14

Filing date

2005-08-12

Publication date

2012-09-01

2005-08-12 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2006-08-16 Publication of TW200628157A publication Critical patent/TW200628157A/zh

2012-09-01 Application granted granted Critical

2012-09-01 Publication of TWI371278B publication Critical patent/TWI371278B/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

TW094127587A 2004-08-14 2005-08-12 Storage stable perfusion solution for dihydropteridinones TWI371278B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04019363		2004-08-14

Publications (2)

Publication Number	Publication Date
TW200628157A TW200628157A (en)	2006-08-16
TWI371278B true TWI371278B (en)	2012-09-01

Family

ID=34926183

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094127587A TWI371278B (en)	2004-08-14	2005-08-12	Storage stable perfusion solution for dihydropteridinones

Country Status (32)

Country	Link
US (3)	US20060035903A1 (zh)
EP (1)	EP1778238B1 (zh)
JP (1)	JP5048491B2 (zh)
KR (1)	KR101235092B1 (zh)
CN (2)	CN101039676A (zh)
AR (1)	AR050918A1 (zh)
AT (1)	ATE528007T1 (zh)
AU (1)	AU2005274339B2 (zh)
BR (1)	BRPI0513997A (zh)
CA (1)	CA2575821C (zh)
CY (1)	CY1112211T1 (zh)
DK (1)	DK1778238T3 (zh)
EA (1)	EA014237B1 (zh)
EC (1)	ECSP077250A (zh)
ES (1)	ES2375980T3 (zh)
HR (1)	HRP20110966T1 (zh)
IL (1)	IL181306A (zh)
ME (1)	ME01264B (zh)
MX (1)	MX2007001855A (zh)
MY (1)	MY147799A (zh)
NO (1)	NO20070984L (zh)
NZ (1)	NZ553815A (zh)
PE (3)	PE20091583A1 (zh)
PL (1)	PL1778238T3 (zh)
PT (1)	PT1778238E (zh)
RS (1)	RS52043B (zh)
SI (1)	SI1778238T1 (zh)
TW (1)	TWI371278B (zh)
UA (1)	UA92470C2 (zh)
UY (1)	UY29060A1 (zh)
WO (1)	WO2006018221A1 (zh)
ZA (1)	ZA200700425B (zh)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6861422B2 (en) *	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) *	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060035903A1 (en) *	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) *	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) *	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) *	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
EP1632493A1 (de) *	2004-08-25	2006-03-08	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) *	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) *	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
TW200808325A (en) *	2006-07-06	2008-02-16	Astrazeneca Ab	Novel compounds
EP2073803B1 (en)	2006-10-12	2018-09-19	Astex Therapeutics Limited	Pharmaceutical combinations
US8883790B2 (en)	2006-10-12	2014-11-11	Astex Therapeutics Limited	Pharmaceutical combinations
KR20140104060A (ko)	2006-10-19	2014-08-27	시그날 파마소티칼 엘엘씨	헤테로아릴 화합물, 이들의 조성물 그리고 단백질 키나아제 억제제로서의 이들의 용도
GB0621203D0 (en) *	2006-10-25	2006-12-06	Chroma Therapeutics Ltd	PLK inhibitors
EP2185559A1 (en) *	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
US20090291938A1 (en) *	2007-11-19	2009-11-26	Takeda Pharmaceutical Company Limited	Polo-like kinase inhibitors
CN102190669A (zh) *	2010-03-19	2011-09-21	江苏恒瑞医药股份有限公司	二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
PL2571503T3 (pl)	2010-05-14	2015-06-30	Dana Farber Cancer Inst Inc	Kompozycje i sposoby leczenia nowotworu, choroby zapalnej i innych zaburzeń
MX354217B (es)	2010-05-14	2018-02-19	Dana Farber Cancer Inst Inc	Composiciones y metodos para el tratamiento de leucemia.
CA2799381A1 (en)	2010-05-14	2011-11-17	Dana-Farber Cancer Institute, Inc.	Male contraceptive compositions and methods of use
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
AR085406A1 (es)	2011-02-25	2013-09-25	Takeda Pharmaceutical	Oxazinopteridinas y oxazinopteridinonas n-sustituidas
US20130131069A1 (en)	2011-05-13	2013-05-23	Boehringer Ingelheim International Gmbh	Method for treatment of solid malignancies including advanced or metastatic solid malignancies
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
WO2013049033A1 (en) *	2011-09-26	2013-04-04	Cary Douglas D	Bladder catheter irrigation method and composition
TW201414734A (zh)	2012-07-10	2014-04-16	Takeda Pharmaceutical	氮雜吲哚衍生物
US20140154304A1 (en)	2012-11-30	2014-06-05	Boehringer Ingelheim International Gmbh	Combination therapy with volasertib
US9714946B2 (en)	2013-03-14	2017-07-25	Dana-Farber Cancer Institute, Inc.	Bromodomain binding reagents and uses thereof
MX2016001037A (es)	2013-07-25	2016-11-10	Dana Farber Cancer Inst Inc	Inhibidores de factores de transcripción y usos.
JP2016525532A (ja)	2013-07-26	2016-08-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	骨髄異形成症候群の処置
MX379463B (es)	2013-11-08	2025-03-10	Dana Farber Cancer Inst Inc	Terapia de combinación para el cáncer usando inhibidores de la proteína bromodominio y extra-terminal.
TW201620904A (zh)	2014-01-09	2016-06-16	武田藥品工業有限公司	氮雜吲哚衍生物
US10150756B2 (en)	2014-01-31	2018-12-11	Dana-Farber Cancer Institute, Inc.	Diaminopyrimidine benzenesulfone derivatives and uses thereof
JP2017504650A (ja)	2014-01-31	2017-02-09	ダナ−ファーバーキャンサーインスティテュート，インコーポレイテッド	ジアゼパン誘導体およびその使用
EP3099693A4 (en)	2014-01-31	2017-08-16	Dana-Farber Cancer Institute, Inc.	Uses of diazepane derivatives
KR20160111520A (ko) *	2014-01-31	2016-09-26	다나-파버 캔서 인스티튜트 인크.	디히드로프테리디논 유도체 및 그의 용도
JP2017506666A (ja)	2014-02-28	2017-03-09	テンシャセラピューティクス，インコーポレイテッド	高インスリン血症に関連した症状の処置
WO2016022970A1 (en)	2014-08-08	2016-02-11	Dana-Farber Cancer Institute, Inc.	Dihydropteridinone derivatives and uses thereof
RU2017104897A (ru)	2014-08-08	2018-09-10	Дана-Фарбер Кэнсер Инститьют, Инк.	Производные диазепана и их применения
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
EP3212654B1 (en)	2014-10-27	2020-04-08	Tensha Therapeutics, Inc.	Bromodomain inhibitors
WO2016105518A1 (en) *	2014-12-23	2016-06-30	Dana-Farber Cancer Institute, Inc.	Methods to induce targeted protein degradation through bifunctional molecules
WO2016171446A1 (ko) *	2015-04-20	2016-10-27	동아에스티 주식회사	펩타이드 붕소산 화합물을 함유하는 안정화 약학 제제
RU2018112953A (ru)	2015-09-11	2019-10-14	Дана-Фарбер Кэнсер Инститьют, Инк.	Ацетамидтиенотриазолодиазепины и пути их применения
PE20181287A1 (es)	2015-09-11	2018-08-07	Dana Farber Cancer Inst Inc	Ciano tienotriazolpirazinas y usos de las mismas
US10913752B2 (en)	2015-11-25	2021-02-09	Dana-Farber Cancer Institute, Inc.	Bivalent bromodomain inhibitors and uses thereof
WO2019145410A1 (en)	2018-01-25	2019-08-01	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia
US11801244B2 (en) *	2018-02-02	2023-10-31	Eustralis Pharmaceuticals Limited	Parenteral formulations and uses thereof
CN109400608B (zh) *	2018-12-15	2021-08-31	西南大学	二氮杂螺[4，5]癸烷酒石酸类衍生物制备和应用

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8303657A (nl)	1983-10-24	1985-05-17	Pharmachemie Bv	Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DE3537761A1 (de) *	1985-10-24	1987-04-30	Bayer Ag	Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
US5316759A (en) *	1986-03-17	1994-05-31	Robert J. Schaap	Agonist-antagonist combination to reduce the use of nicotine and other drugs
JPH0276860A (ja) *	1987-10-05	1990-03-16	Toyo Jozo Co Ltd	６−置換アルコキシ−２−オキソ−１，２−ジヒドロキノキサリン誘導体
FR2645152B1 (fr) *	1989-03-30	1991-05-31	Lipha	3h-pteridinones-4, procedes de preparation et medicaments les contenant
CA2029651C (en)	1989-11-17	2000-06-06	David D. Davey	Tricyclic pteridinones and a process for their preparation
US5198547A (en) *	1992-03-16	1993-03-30	South Alabama Medical Science Foundation, Usa	Process for N5-formylating tetrahydropteridines
TW274550B (zh) *	1992-09-26	1996-04-21	Hoechst Ag
EP1195372A1 (en) *	1994-04-18	2002-04-10	Mitsubishi Pharma Corporation	N-heterocyclic substituted benzamide derivatives with antihypertensive activity
GB9418499D0 (en)	1994-09-14	1994-11-02	Ciba Geigy Ag	Process for producing n-methylated organic pigments
CO4410190A1 (es)	1994-09-19	1997-01-09	Lilly Co Eli	3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
EP0825979B1 (en) *	1995-05-19	2001-01-03	Novartis AG	Process for the catalytic hydrogenation of aromatic nitro compounds
US5698556A (en) *	1995-06-07	1997-12-16	Chan; Carcy L.	Methotrexate analogs and methods of using same
HU226167B1 (hu)	1996-09-23	2008-05-28	Lilly Co Eli	Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
AP2001002068A0 (en) *	1998-08-11	2001-03-31	Pfizer Prod Inc	Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors.
NZ516872A (en)	1999-09-15	2003-10-31	Warner Lambert Co	Pteridinones as kinase inhibitors
GB2359551A (en) *	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
CA2401368A1 (en)	2000-03-06	2001-09-27	Warner-Lambert Company	5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
DE10018783A1 (de) *	2000-04-15	2001-10-25	Fresenius Kabi De Gmbh	Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
US20020183292A1 (en) *	2000-10-31	2002-12-05	Michel Pairet	Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10058119A1 (de) *	2000-11-22	2002-05-23	Bayer Ag	Pepinotan-Kit
US6756374B2 (en)	2001-01-22	2004-06-29	Hoffmann-La Roche Inc.	Diaminothiazoles having antiproliferative activity
WO2002076954A1 (en)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6806272B2 (en) *	2001-09-04	2004-10-19	Boehringer Ingelheim Pharma Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
JP3876254B2 (ja) *	2001-09-04	2007-01-31	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規なジヒドロプテリジノン、その製造方法及びその医薬組成物としての使用
ATE526013T1 (de) *	2001-12-14	2011-10-15	Merck Serono Sa	Verfahren zur herbeiführung einer ovulation über einen nicht-polypeptid-camp-spiegel-modulator
RU2004135533A (ru)	2002-05-03	2005-07-20	Шеринг Акциенгезельшафт (De)	Тиазолидиноны и их применение в качестве ингибиторов polo- подобной киназы
FR2843114B1 (fr) *	2002-08-01	2004-09-10	Poudres & Explosifs Ste Nale	Procede de monomethylation d'heterocycles azotes
RU2296758C2 (ru)	2002-08-08	2007-04-10	Смитклайн Бичем Корпорейшн	Производные тиофена
HRP20050735B1 (hr)	2003-02-26	2013-08-31	Boehringer Ingelheim Pharma Gmbh & Co.Kg	Dihidropteridinoni, metoda za njihovu proizvodnju i upotrebu u obliku lijekova
US6861422B2 (en) *	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
JP2006523224A (ja)	2003-03-26	2006-10-12	ワイス	免疫原性組成物および方法
WO2004093848A2 (en)	2003-04-14	2004-11-04	Vectura Ltd	Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
DE102004002557A1 (de) *	2004-01-17	2005-08-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
EP1708715A1 (de) *	2004-01-17	2006-10-11	Boehringer Ingelheim International GmbH	Verwendung von substituierten pteridinen zur behandlung von atemwegserkrankungen
DE102004029784A1 (de) *	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
DE102004034623A1 (de) *	2004-07-16	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US7728134B2 (en) *	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060058311A1 (en) *	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
EP1630163A1 (de) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) *	2004-08-25	2006-03-08	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006021547A1 (de)	2004-08-26	2006-03-02	Boehringer Ingelheim International Gmbh	Pteridinone als plk (polo like kinase) inhibitoren
EP1784406A1 (de) *	2004-08-27	2007-05-16	Boehringer Ingelheim International GmbH	Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE102004058337A1 (de) *	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
JP2009503014A (ja) *	2005-08-03	2009-01-29	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	呼吸器系疾患の治療におけるジヒドロプテリジノン
EP1948180B1 (en)	2005-11-11	2013-03-13	Boehringer Ingelheim International GmbH	Combination treatment of cancer comprising egfr/her2 inhibitors
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
US20090023733A1 (en) *	2006-03-07	2009-01-22	Peter Cage	Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
SG174054A1 (en) *	2006-05-04	2011-09-29	Boehringer Ingelheim Int	Polymorphs
EP2185559A1 (en) *	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
JP4642085B2 (ja)	2008-01-17	2011-03-02	日本下水道事業団	予測健全度を利用した施設管理および更新計画システム
EP2100894A1 (en)	2008-03-12	2009-09-16	4Sc Ag	Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
EP2536725B1 (en)	2010-02-17	2015-10-28	Boehringer Ingelheim International GmbH	Dihydropteridinones, method for production and use thereof
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) *	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US20130131069A1 (en)	2011-05-13	2013-05-23	Boehringer Ingelheim International Gmbh	Method for treatment of solid malignancies including advanced or metastatic solid malignancies
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors

2005
- 2005-08-05 US US11/197,927 patent/US20060035903A1/en not_active Abandoned
- 2005-08-11 RS RS20110504A patent/RS52043B/sr unknown
- 2005-08-11 DK DK05778137.9T patent/DK1778238T3/da active
- 2005-08-11 CN CNA2005800352739A patent/CN101039676A/zh active Pending
- 2005-08-11 BR BRPI0513997-0A patent/BRPI0513997A/pt active Search and Examination
- 2005-08-11 JP JP2007526359A patent/JP5048491B2/ja not_active Expired - Lifetime
- 2005-08-11 EA EA200700389A patent/EA014237B1/ru not_active IP Right Cessation
- 2005-08-11 PT PT05778137T patent/PT1778238E/pt unknown
- 2005-08-11 CN CN201610003590.2A patent/CN105640874A/zh active Pending
- 2005-08-11 SI SI200531439T patent/SI1778238T1/sl unknown
- 2005-08-11 NZ NZ553815A patent/NZ553815A/en not_active IP Right Cessation
- 2005-08-11 UA UAA200702575A patent/UA92470C2/ru unknown
- 2005-08-11 ME MEP-2011-184A patent/ME01264B/me unknown
- 2005-08-11 CA CA2575821A patent/CA2575821C/en not_active Expired - Lifetime
- 2005-08-11 AT AT05778137T patent/ATE528007T1/de active
- 2005-08-11 WO PCT/EP2005/008735 patent/WO2006018221A1/de not_active Ceased
- 2005-08-11 MX MX2007001855A patent/MX2007001855A/es active IP Right Grant
- 2005-08-11 ES ES05778137T patent/ES2375980T3/es not_active Expired - Lifetime
- 2005-08-11 HR HR20110966T patent/HRP20110966T1/hr unknown
- 2005-08-11 AU AU2005274339A patent/AU2005274339B2/en not_active Ceased
- 2005-08-11 KR KR1020077005957A patent/KR101235092B1/ko not_active Expired - Fee Related
- 2005-08-11 EP EP05778137A patent/EP1778238B1/de not_active Expired - Lifetime
- 2005-08-11 PL PL05778137T patent/PL1778238T3/pl unknown
- 2005-08-12 TW TW094127587A patent/TWI371278B/zh not_active IP Right Cessation
- 2005-08-12 MY MYPI20053807A patent/MY147799A/en unknown
- 2005-08-12 PE PE2009000399A patent/PE20091583A1/es not_active Application Discontinuation
- 2005-08-12 AR ARP050103382A patent/AR050918A1/es unknown
- 2005-08-12 UY UY29060A patent/UY29060A1/es not_active Application Discontinuation
- 2005-08-12 PE PE2009001171A patent/PE20100447A1/es not_active Application Discontinuation
- 2005-08-12 PE PE2005000937A patent/PE20060645A1/es not_active Application Discontinuation
2007
- 2007-01-15 ZA ZA200700425A patent/ZA200700425B/xx unknown
- 2007-02-13 IL IL181306A patent/IL181306A/en not_active IP Right Cessation
- 2007-02-14 EC EC2007007250A patent/ECSP077250A/es unknown
- 2007-02-21 NO NO20070984A patent/NO20070984L/no not_active Application Discontinuation
2009
- 2009-02-06 US US12/366,730 patent/US8445675B2/en active Active
2012
- 2012-01-05 CY CY20121100009T patent/CY1112211T1/el unknown
2013
- 2013-04-23 US US13/868,591 patent/US20130245013A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR101235092B1 (ko)	2013-02-20
US20090143379A1 (en)	2009-06-04
CN105640874A (zh)	2016-06-08
MX2007001855A (es)	2007-03-28
CY1112211T1 (el)	2015-12-09
ZA200700425B (en)	2008-10-29
UA92470C2 (ru)	2010-11-10
JP5048491B2 (ja)	2012-10-17
WO2006018221A1 (de)	2006-02-23
PT1778238E (pt)	2011-11-25
IL181306A0 (en)	2007-07-04
WO2006018221A9 (de)	2011-04-28
AU2005274339B2 (en)	2011-05-19
PE20100447A1 (es)	2010-06-25
MY147799A (en)	2013-01-31
AR050918A1 (es)	2006-12-06
TW200628157A (en)	2006-08-16
US8445675B2 (en)	2013-05-21
ECSP077250A (es)	2007-03-29
ME01264B (me)	2013-06-20
EP1778238A1 (de)	2007-05-02
PE20091583A1 (es)	2009-11-14
RS52043B (sr)	2012-04-30
DK1778238T3 (da)	2012-02-06
SI1778238T1 (sl)	2012-02-29
NZ553815A (en)	2010-12-24
JP2008509952A (ja)	2008-04-03
PE20060645A1 (es)	2006-08-01
US20130245013A1 (en)	2013-09-19
WO2006018221A8 (de)	2006-06-15
EP1778238B1 (de)	2011-10-12
US20060035903A1 (en)	2006-02-16
UY29060A1 (es)	2006-03-31
KR20070053253A (ko)	2007-05-23
EA200700389A1 (ru)	2007-08-31
NO20070984L (no)	2007-05-10
AU2005274339A1 (en)	2006-02-23
CN101039676A (zh)	2007-09-19
HRP20110966T1 (hr)	2012-01-31
CA2575821A1 (en)	2006-02-23
ES2375980T3 (es)	2012-03-07
EA014237B1 (ru)	2010-10-29
IL181306A (en)	2014-07-31
CA2575821C (en)	2013-07-02
ATE528007T1 (de)	2011-10-15
BRPI0513997A (pt)	2008-05-20
PL1778238T3 (pl)	2012-03-30

Publication	Publication Date	Title
TWI371278B (en)	2012-09-01	Storage stable perfusion solution for dihydropteridinones
GB2430420B (en)	2009-03-25	Storage System
GB2412481B (en)	2007-06-27	Storage system
EP1731882A4 (en)	2013-03-06	STRUCTURE FOR AGENT CONTAINER R DUTOR
EP1821363A4 (en)	2009-09-30	BATTERY MODULE OF ACCUMULATORS
GB2411021B (en)	2006-04-19	Storage system
GB0705056D0 (en)	2007-04-25	Storage system
GB0402909D0 (en)	2004-03-17	Data storage
GB2433421B (en)	2008-09-03	Storage rack
GB0415561D0 (en)	2004-08-11	Hydrogen storage system
SG114698A1 (en)	2005-09-28	Refrigerating storage
GB0422304D0 (en)	2004-11-10	Combined storage apparatus
GB0518307D0 (en)	2005-10-19	Storage system
GB0500733D0 (en)	2005-02-23	Storage system
GB0409146D0 (en)	2004-05-26	Storage system
GB0421668D0 (en)	2004-10-27	Storage units
GB2412205B (en)	2006-02-15	Storage system
HU2901U (en)	2005-04-28	Arrangement for storage of ski
AU157360S (en)	2005-01-25	Storage unit
GB0403521D0 (en)	2004-03-24	Storage unit
GB0522679D0 (en)	2005-12-14	Secure storage unit
GB2422773B (en)	2007-04-18	Storage rack
ITVI20040002A1 (it)	2004-04-12	Dispositivo riunitore per portaoggetti
HU3678U (en)	2009-11-30	Storage system
GB0411219D0 (en)	2004-06-23	Rack storage system

Legal Events

Date	Code	Title	Description
2016-06-01	MM4A	Annulment or lapse of patent due to non-payment of fees